ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization
Author(s) -
Tingting Qin,
Brendan Mullan,
Ramya Ravindran,
Dana Messinger,
Ruby Siada,
Jessica Cummings,
Micah Harris,
Ashwath Muruganand,
Kalyani Pyaram,
Zachary Miklja,
Mary Reiber,
Taylor Garcia,
Dustin Tran,
Carla Danussi,
Jacqueline A. BrosnanCashman,
Drew Pratt,
Xinyi Zhao,
Alnawaz Rehemtulla,
Maureen A. Sartor,
Sriram Venneti,
Alan K. Meeker,
Jason T. Huse,
Meredith A. Morgan,
Pedro R. Löwenstein,
María G. Castro,
Viveka Nand Yadav,
Carl Koschmann
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.110216
Subject(s) - atrx , glioma , cell cycle , cancer research , synthetic lethality , biology , mutant , cell , mutation , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom